1230 AVE OF ANERICAS FL 7 7TH FLOOR NEW YORK, NY 10020 Get Directions
1230 AVE OF ANERICAS FL 7 7TH FLOOR NEW YORK, NY 10020 Get Directions
Phosphagenics Limited is an Australian-based, globally-driven biotechnology company focused on the discovery of new ways to enhance the delivery of proven pharmaceutical, nutraceutical and cosmeceutical active ingredients. Our company's core technology is built around the application of our unique proprietary delivery system, called TPM(TM) Delivery Technology. We produce a range of differentiated products in diverse markets based on our versatile and consumer friendly delivery platform, which is derived from natural Vitamin E. Phosphagenics' lead program is its pain management franchise - including an oxycodone transdermal patch and an oxymorphone transdermal patch - for the relief of chronic pain. Phosphagenics is a pubic company based in Melbourne, Australia (and a small office in Midtown Manhattan) with shares listed on the Australian Securities Exchange (POH). As at April 1st 2013, Phosphagenics has 40 employees and a market capitalization of $US135 million. For more information, see: www.phosphagenics.com.
Phosphagenics Inc. is the US operating company of Phosphagenics Ltd., and it wholly owned by Phosphagenics Ltd.
© Dun & Bradstreet, Inc. 2024. All rights reserved.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.